Guo 2023 - Discovery of Ecnoglutide, a Long-Acting Biased GLP-1 Analog

Molecular Metabolism·September 1, 2023

W. Guo

Summary

Discovery and characterization paper for ecnoglutide, a long-acting cAMP-biased GLP-1 analog developed for type 2 diabetes and obesity.

Study Details

Study Design

Drug discovery and preclinical characterization study

Indication

Type 2 diabetes and obesity pharmacology

Intervention

Ecnoglutide / XW003

Species

Animal

Risk of Bias Assessment

Preclinical discovery study